Search
for
Sort by
Research 61–90 of 1000+
- Glucocorticoid Receptor Mutants Demonstrate Increased Motility Inside the Nucleus of Living Cells: Time of Fluorescence Recovery After Photobleaching (FRAP) Is an Integrated Measure of Receptor Function
- Androgen receptor gene polymorphisms and risk for androgenetic alopecia: a meta-analysis
- Topical latanoprost acid for female androgenetic alopecia: a pilot proof-of-concept trial with mechanistic evidence of prostaglandin F2α receptor activation
- Evaluation of the role of soluble receptors for advanced glycosylated end-products in polycystic ovarian syndrome
- Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development
- Regulation of Hair Shedding by the Type 3 IP3 Receptor
- Glucocorticoid and Sex Hormone Receptors: Clinical Implications and Therapeutic Relevance
- The VEGF +405 G>C 5' untranslated region polymorphism and risk of PCOS: a study in the South Indian Women
- Use of natural molecules as anti-angiogenic inhibitors for vascular endothelial growth factor receptor
- Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes
- A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome
- Outcome and clinical–biological characteristics of patients with advanced breast cancer undergoing removal of ovarian/pelvic metastases
- Anatomical and Dermatologic Manifestations of Estrogen Deficiency in Postmenopausal Women: A Systematic Review
- Sebaceous immunobiology - skin homeostasis, pathophysiology, coordination of innate immunity and inflammatory response and disease associations
- Restricted effects of androgens on glucocorticoid signaling in the mouse prefrontal cortex and midbrain
- Main Plenary Sessions: Summaries of Papers
- Effects of topical application of EGCG on testosterone-induced hair loss in a mouse model
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- A Systematic Review of the Potential Role of Cinnamomum spp. in Modulating Insulin Sensitivity and Hyperandrogenism in Polycystic Ovary Syndrome (PCOS)
- Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness
- Melatonin promotes Cashmere goat (<i>Capra hircus</i>) secondary hair follicle growth: a view from integrated analysis of long non-coding and coding RNAs
- Purple corn extract improves benign prostatic hyperplasia by inhibiting 5 alpha-reductase type 2 and inflammation in testosterone propionate-induced rats
- Spinal and bulbar muscular atrophy: pathogenesis and clinical management
- The Role of Oral Contraceptives in the Treatment of Hyperandrogenic Disorders
- Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome
- Protective effects of melatonin against metabolic and reproductive disturbances in polycystic ovary syndrome in rats
- UTILIDADES DE LA ESPIRONOLACTONA COMO FÁRMACO ANTIANDROGÉNICO
- GPCRs as key regulators in wound healing
- Expression of 11β-hydroxysteroid dehydrogenase type 1 in visceral and subcutaneous adipose tissues of patients with polycystic ovary syndrome is associated with adiposity
- Targets to treat androgen excess in polycystic ovary syndrome